Nashville Biosciences
Amber Watson has extensive work experience in the healthcare and pharmaceutical industry. Amber is currently serving as the Assistant Medical Director at Nashville Biosciences since March 2021. Prior to this, they worked as a Freelance Drug Content Medical Reviewer and Freelance Drug Content Writer at RVO Health starting from September 2020.
Amber has also worked at MedLogix Communications, LLC where they held the positions of Freelance Medical Writer from March 2019 to September 2021 and Medical Writer from November 2019 to March 2021.
Before that, they worked at axialHealthcare as a Clinical Pharmacist, Scientific Writer from October 2018 to October 2019, and as a Clinical Product Specialist from January 2018 to October 2018.
Amber's earlier experience includes working at Aegis Sciences Corporation as a Clinical Pharmacist, Healthcare Services from June 2016 to December 2017, and as a Clinical Pharmacist Fellow in Drug Information from June 2015 to June 2016. Amber also served as a Clinical Pharmacist Fellow and Adjunct Faculty at Belmont University's College of Pharmacy from June 2015 to June 2016.
Amber Watson attended The University of Tennessee Health Science Center from 2011 to 2015, where they obtained their Doctor of Pharmacy (Pharm.D.) degree with a specialization in Pharmacy. In addition to their degree, they also obtained a Teaching Certificate from Belmont University - College of Pharmacy in December 2015 and a Tennessee Pharmacists License from the Tennessee Department of Health in July 2015. Amber also has a certification in Green Belt (GB) from the Haslam College of Business at the University of Tennessee, although the specific date of obtaining this certification is not mentioned.
This person is not in any teams
Nashville Biosciences
Nashville Biosciences, a wholly owned subsidiary of Vanderbilt University Medical Center, was created to harness the medical center's extensive genomic and bioinformatics resources for drug and diagnostics discovery and development. Leveraging Vanderbilt University Innovation™, Nashville Biosciences serves as a commercial interface between outside companies and the formidable research capabilities housed within Vanderbilt University Medical Center, including BioVU®, one of the world’s most comprehensive genetic databases linked to de-identified medical records with years of longitudinal clinical data. This unique asset is one of the largest and highest quality of its kind, providing an unprecedented opportunity to guide R&D activity in biotech, pharma, diagnostics, medical devices and other life sciences applications.